Translational Development Acquisition Corp. Ordinary Shares (TDAC) — Cash Flow Quality Index
Latest as of September 2025:
-0.75x
Translational Development Acquisition Corp. Ordinary Shares (TDAC) has a Cash Flow Quality Index of -0.75x as of September 2025. Operating cash flow of $-1.24 Million is below net income of $1.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Translational Development Acquisition Co balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-0.75x
Operating CF / Net Income
Operating Cash Flow
$-1.24 Million
USD
Net Income
$1.66 Million
USD
Data as of
Sep 2025
Most recent filing
Annual Cash Flow Quality Index for Translational Development Acquisition Corp. Ordinary Shares (None–None)
Year-by-year earnings quality comparison for Translational Development Acquisition Corp. Ordinary Shares. For live market cap and the full company financial profile, see Translational Development Acquisition Co market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.